Of interest in 2010: the Anthos 2010 microplate reader
Order before 30 June for free software upgrade
Four filters are supplied as standard that cover the wavelengths for most common absorbance assays with a colorimetric endpoint, e.g. ELISA, BCA, Bradford and Lowry assays, and additional filters are available.
A choice of software packages enables the user to connect to a PC and run both endpoint and kinetic assays with ease. Results can be printed directly or exported to a spreadsheet for further analysis.
Order the Biochrom Anthos 2010 instrument before the end of June 2010 and the user will receive a free software upgrade to program the plate layout with blanks, standards and controls. This permits the user to perform qualitative analysis on the results or quantify unknown samples using a standard curve eliminating outliers.
The Biochrom Anthos range of high performance microplate instrumentation is manufactured by Biochrom and available worldwide.
For complete specifications on the Biochrom Anthos microplate readers as well as the complete Biochrom product line go to www.Biochrom.co.uk
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model